期刊
FUTURE ONCOLOGY
卷 10, 期 7, 页码 1187-1202出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fon.13.263
关键词
biomarkers; diagnostic; gastric cancer; GDF15; metastasis; miR-200c; MMP7; prognostic
类别
资金
- Instituto de Salud Carlos III (Spain) [CA0900116]
- Secretaria Xeral I+D+I (Xunta de Galicia, Spain) [IPP0807]
- Instituto de Salud Carlos III, Spain [PI061541]
- ServizoGalego de Saude, Xunta de Galicia, Spain [PS0877]
Aim: To analyze GDF15 and MMP7 serum levels as diagnostic biomarkers in gastric cancer (GC) patients. The prognostic value of GDF15 and MMP7 serum levels in combination with miR-200c blood expression was also analyzed. Patients & methods: Fifty-two GC and 23 control samples were included. Results: GDF15 and MMP7 proved to be powerful tools for GC diagnosis. Increased levels of GDF15 and MMP7 were associated with shorter progression-free survival and overall survival in univariate analysis. In multivariate analysis, the combination of high levels of GDF15, MMP7 and miR-200c was an independent predictor for death (p = 0.033). Conclusion: GDF15 and MMP7 serum levels have diagnostic value for GC. The combination marker formed by GDF15, MMP7 and miR-200c is indicative of adverse evolution in GC patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据